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Abstract
Introduction Mucopolysaccharidosis (MPS) represent a het-
erogeneous group of inheritable lysosomal storage diseases in
which the accumulation of undegraded glycosaminoglycans
(GAGs) leads to progressive damage of affected tissues. The
typical symptoms include organomegaly, dysostosis multi-
plex, mental retardation and developmental delay. Definitive
diagnosis is usually possible through enzymatic assays of the
defective enzyme in cultured fibroblasts or leukocytes.
Imaging findings Radiological and neuroradiological find-
ings are reported. The most important neuroradiological
features include abnormal signal intensity in the white mat-
ter, dilatation of periventricular spaces, widening of cortical
sulci, brain atrophy, enlargement of extraventricular spaces
and spinal cord compression. With reference to the skeletal
system, most important radiological findings include multi-
plex dysostosis, which is represented by several bone
malformations found in the skull, hands, legs, arms and
column. The abnormal storage of GAGs leads to liver and
spleen enlargement; it also damages cartilage layers and
synovial recesses in the joints.
Conclusion The aim of this pictorial essay is to describe the
imaging findings of MPS, represented by skeletal and neu-
rological features; skeletal X-ray and MR allow an assess-
ment of the severity of disease, to plan medical and surgical
therapy and to evaluate response to treatment.
Teaching Points
• To describe the imaging findings common to different types
of MPS.
• To describe multiplex dysostosis encountered in the axial
and appendicular skeleton.
• To evaluate neuroradiological features of MPS, including
brain abnormal signal intensity and atrophy.
• To evaluate important otorhinolaryngological problems,
such as otitis media and airways obstruction.
Keywords Glycosaminoglycans . Metabolic diseases .
Lysosomal storage diseases . Dysostoses . Magnetic
resonance imaging
Introduction
The mucopolysaccharidoses (MPS) are a group of heritable
lysosomal storage disorders caused by a deficiency in glycos-
aminoglycan (GAG)-degrading enzymes. The resulting accu-
mulation of unprocessed or partly processed GAGs—dermatan
sulphate, heparan sulphate, keratan sulphate and chondroitin
sulphate—in lysosomes causes progressive damage of affected
tissues, including heart, respiratory system, bones, joints and
central nervous system [1]. Seven distinct clinical types ofMPS
have been identified and described in the literature, caused by
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11 different enzymatic deficiencies. Even if each type of MPS
presents a rare incidence, the overall incidence is not negligible
(1 in 25,000 live births). Transmission occurs in an autosomal
recessive fashion, except for MPS II, which is X-linked [2].
The ubiquitous nature of GAGs within the connective
tissue of the body results in a wide range of clinical effects.
The type of GAGs stored and the classification of disease
depend on the specific enzyme deficiency [3]. Table 1 out-
lines the latest classification, with details of the accumulat-
ing compounds and enzymes deficiencies, as well as the
eponym used for each condition.
Like most genetic disorders, there is a continuous spec-
trum of phenotype from the very severe to the most mildly
affected; many mutations are responsible for these pheno-
typic differences [2]. The typical symptoms, encountered in
the majority of MPS, include organomegaly, dysostosis
multiplex, mental retardation and developmental delay. Oto-
logical (otitis media) and respiratory (airway obstruction)
problems can also be present. Other manifestations include
impaired vision (corneal clouding and photophobia) [4] and
cardiovascular involvement (myocardial hypertrophy, sys-
tolic dysfunction and valve dysfunction) [5–7].
The course of MPS is variable from very severe forms,
with an average expected life span of 1 or 2 decades
(neuronopathic forms in particular are usually fatal diseases)
to attenuated or slowly progressing ones that allow the
patient to reach adulthood [1, 3, 8].
A combination of clinical picture and analysis of urinary
GAGs is usually performed to achieve the diagnosis of
MPS, even though this method cannot recognise subtypes;
definitive diagnosis is usually possible through measuring
enzyme activity in cultured fibroblasts or leukocytes [1, 2].
Treatment consists mainly of symptomatic and support-
ive care, including decompression of the craniocervical
narrowing, tracheostomy insertion and corneal transplanta-
t ion . In recent year s the deve lopment of new
therapies—represented by enzyme replacement therapies,
substrate inhibition therapy and haematopoietic cell
transplantation—have changed the treatment of these pa-
tients, with a fundamental shift in the approach from symp-
tomatic management to therapeutic intervention; in many
cases, the introduction of these new therapies has signifi-
cantly improved the duration and quality of life for patients
[9, 10].
Table 1 Summary of epidemiological, pathophysiological and clinical features characterising different types of MPS
Type Name of syndrome Incidence Deficient enzyme Accumulated
products
Main symptoms
I Hurler (I H) 1/100.000 Alpha-L-iduronidase HS Corneal clouding; dysostosis multiplex;
organomegaly; heart disease; mental
retardation; death in childhood
DS Corneal clouding; stiff joints; normal
intelligence and life span
Scheie (I S) Intermediate phenotype, between MPS
IH and MPS ISHurler-Scheie (I H-S)
II Hunter 1/250.000 Iduronate sulphatase HS Dysostosis multiplex; organomegaly;
short stature; death before 15 years
(severe);survival to 20s to 60s (mild)
DS




Sanfilippo C Acetyl-CoA: alpha-glucusaminide
acetyltranferase
Sanfilippo D N-acetylglucosamine 6-sulphatase
IV Morquio A 1/75.000 Galactose-6-sulphate sulphatase KS Dysostosis multiplex; short stature;
motor dysfunctionMorquio B CH
Beta-galactosidase KS
V This designation is no longer used; the phenotype, which was first classified as MPS V, was found to be MPS I S
VI Maroteaux-Lamy <1/250.000 N-acetylgalactosamine-4-sulphatase DS Dysostosis multiplex; short stature;
motor dysfunction; kyphosis; heart
defects; survival to teens in
severe form
VII Sly <1/250.000 Beta-glucuronidase HS Hepatomegaly; dysostosis multiplex;
short stature; corneal clouding;
developmental delay; wide spectrum
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Imaging findings
In patients with MPS, radiological and neuroradiological
imaging findings have been described [11]. The most im-
portant radiological findings occur in the skeletal system
with multiplex dysostosis (Table 2), a complex of anomalies
involving several bones [12–14], dominating the clinical
picture in MPS IV and MPS VI.
The abnormal storage of GAG in the mouth, nose, phar-
ynx and larynx results in several otorhinolaryngological
disorders; in view of this, otorhinolaryngological imaging
findings have been described. Patients can also show hepa-
tomegaly and splenomegaly.
Regarding neuroradiological features, the involvement of
the central nervous system is predominant in MPS I, II, III
and MPS VII [15, 16].
In this pictorial review we focus on skeletal, otorhinolar-
yngological and neuroradiological imaging findings en-
countered in patients with MPS.Table 2 Radiological skeletal manifestations of MPS: dysostosis
multiplex
Dysostosis multiplex
Skull Macrocephaly with dolicocephaly
Vertical frontal crest
Abnormal J-shaped sella turcica
Thickened cortical bone
Facial anomalies
Lack of pneumatization of mastoid
process
cells and of paranasal cavities
Obtuse mandibular angle with
prognatism
Teeth widely spaced
Thorax Paddle-shaped or oar-shaped ribs
(widened
anteriorly and tapered posteriorly)
Short and thickened clavicles
Spine Craniovertebral junction: atlantoaxial
instability, stenosis and compression
of the spinal cord
Thoracolumbar spine: gibbus
Malformations of the vertebral bodies
Pelvis Rounded iliac wings
Inferior tapering of the ileum
Hip dysplasia
Poorly developed acetabulum
Underdevelopment of the medial
portion of the proximal femoral
epiphysis
Coxa valga
Long bones Mildly hypoplastic epiphyses
Proximal humeral notching
Long and narrow femoral neck
Knees Genu valgum
Hands and feet V-shaped deformity of the
hypoplastic
distal ulna and radius
Hypoplastic and irregularly shaped
carpal
and tarsal bones
Proximal pointed metacarpals and
metatarsals
Bullet-shaped phalanges
Fig. 1 Magnified views of lateral skull radiographs. Normal skull,
presenting a regularly shaped sella (a). Skull of a 2-year-old patient
affected by MPS VI (b); the abnormal J-shaped sella (white arrow), is
clearly recognisable. Skull of a 17-year-old patient affected by MPS VI
(c), presenting a J-shaped sella (white arrow) and some molars
unerupted and angulated in both the jaws (white arrowheads)
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Skeletal imaging findings
Axial skeleton
The most important radiological findings in the axial skele-
ton regard the skull, thorax, spine and pelvis.
The skull is often characterised by an abnormal “J-
shaped” conformation of the sella turcica, seen on the lateral
view of the cranium (Fig. 1). The sella turcica is normally a
saddle-shaped depression in the sphenoid bone, while in
MPS patients it is usually wide with long clinoid apophyses
and horizontal orientation: the tuberculum sellae is flattened
and the dorsum sellae is rounded, respectively, forming the
straight edge and the loop of the “J”. This configuration may
represent a normal anatomic variant and may be associated
with neurofibromatosis or with a slow-growing tumour ad-
jacent to the sella, such as an optic chiasm glioma, so the “J-
shaped” sella turcica is characteristic, but not diagnostic of
mucopolysaccharidosis.
The cortical bone of the skull is thickened. The premature
closure of the sagittal suture is responsible for the develop-
ment of macrocephaly with dolicocephaly, plus the metopic
perisutural hyperostosis causes a vertical frontal crest. The
most important facial anomalies are represented by the lack
of pneumatization of mastoid cells and paranasal cavities;
the mandible is short and broad, mandibular condyles are
undeveloped and the temporomandibolar joint may exhibit
limited motion; unerupted and widely spaced teeth can also
be found (Fig. 1).
Concerning the thorax, the main abnormality concerns
the ribs, which can be “paddle-shaped” or “oar-shaped”
because of the widening of the anterior archs and of the
tapering of the posterior ones. Other common modifications
are small scapulae, usually with flattening of the glenoid
Fig. 3 Spine abnormality.
Sagittal T2-weighted fast spin-
echo image (a); sagittal T1-
weighted fast spin-echo image
(b). The figures show the entire
spine of a 14-year-old female




arrow) and nucleus pulposus
hypotrophy (white arrowhead)
are well depicted; gibbus at
thoracolumbar region is also
seen
Fig. 2 Thoracic abnormality.
Frontal radiographs showing a
normal chest in a 10-year-old
girl (a) and a chest of a 10-year-
old girl affected by MPS IV (b),
the latter presenting ribs (white
arrowheads) tapered proximally
and wider distally; broad and
short clavicles (white arrow) can
be seen in the magnified view of
the clavicles (c)
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cavities, a short sternum and short and thickened aspect of
the clavicles (Fig. 2) [17].
Issues affecting the spine are extremely common (Figs. 3
and 4), and MPS patients may risk important complications
due to compression on the spinal cord and emerging nerve
roots.
At the craniovertebral junction level, the most important
abnormalities are:
& odontoid process displasia-hypoplasia;
& atlantoaxial instability or subluxation;
& periodontoid tissue and ligaments thickening;
& spinal stenosis.
These features represent a critical aspect in MPS (partic-
ularly in MPS IV), because if the spinal cord is compressed,
cervical myelopathy may result. MRI is more appropriate
for the evaluation of spinal cord alterations.
Modifications of the shape of vertebral bodies are very
common, resulting in flattened and rounded vertebrae
(Fig. 5). At the thoraco-lumbar level the vertebral body can
show a deficiency in its anterosuperior corner and, as a con-
sequence, an apparent prolongation of the anteroinferior one,
resulting on the lateral X-ray in an “anterior beaking” aspect.
When hypoplasia of both anterior corners occurs, the vertebral
body is wedge-shaped.
Fig. 5 X-ray of multiplex
dysostosis of the spine. A 4-
year-old child with Hurler
syndrome shows vertebral
bodies rounded (white arrow, a
and b). The “anterior beaking”
aspect (white arrowhead, c)
with posterior scalloping and
the platyspondylia with
“wedge-shaped” deformity
(curved white arrow, d) are
observed in other radiographs
of different MPS patients
Fig. 4 Deformation of the
spine. MRI of the spine of a 12-
year-old female with MPS VI.
Sagittal T2-weighted (a),
sagittal T1-weighted (b) and
coronal T2-weighted (c) fast
spin-echo MRI acquisitions
demonstrate marked kypho-
scoliotic deformation of the
spine, with disc hernias and
vertebral bodies deformities
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Fig. 8 Appearances of
multiplex dysostosis. A 6-year-
old boy with MPS II.
Radiographs show several
morphological appearances of
multiplex dysostosis in long
bones, with proximal humeral
notching (white arrow, a), long
and narrow femoral neck (curved
white arrow, b), and frayed and
flared tibial metaphyses (c). All
segments, particularly those of
the upper limb, are short and
squat; they also have hypoplastic
epiphyses, cortical thinning and
flaring of the diaphyseal canal
Fig. 7 Multiplex dysostosis of
the pelvis. X-ray of the pelvis in
a healthy child (a). Images of
the pelvis of MPS patients (b–
d) showing typical imaging
findings of disease: rounded
iliac wings, inferior tapering of
the ilea with a poorly developed
acetabulum, underdeveloped
medial portion of the proximal
femoral epiphysis, increased
coxofemoral joint space and
coxa valga are well depicted in
b–d
Fig. 6 A 45-year-old female
suffering from MPS IV
(Morquio disease). Sagittal
MRI T2-weighted (a) and T1-
weighted (b) fast spin-echo
acquisitions of the cervico-
thoracic spine show severe
kypho-scoliosis with narrowing
of the spinal canal
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These vertebral morphologic changes may progressively
evolve to gibbus deformity (Fig. 6), particularly in MPS I.
Scoliosis is usually not bad enough to require surgery;
however, myelopathy can represent an indication of the
need for surgical treatment [12].
The most common radiological features in the pelvis
are rounded iliac wings and inferior tapering of the
ileum (Fig. 7) [18]. The alterations of the hip joint
can lead to hip dysplasia because of the poor develop-
ment of the acetabulum and the underdevelopment of
the medial portion of the proximal femoral epiphysis.
This alteration has not been shown to respond to med-
ical therapy, so for these children surgical reconstruction
is often required; the target of this treatment is the
optimisation of hip mechanics [12].
Peripheral skeleton
In MPS patients, the long bones are often characterised by
several alterations. Diaphyses are shortened and curved in
the distal part; the epiphyses are slightly hypoplastic and
thinned cortically with osteoporosis [15]. Other features that
can be found are the notching of the proximal part of the
humerus, the long and narrow aspect of the femoral neck
(Fig. 8), and the hypoplasia of the lateral tibial hemiplate,
resulting in genu valgum.
Knees can also be involved, particularly in children with
MPS IV and MPS I, developing genu valgum (Fig. 9). This
condition is sometimes severe enough to require surgery. In
adulthood an advanced state of arthrosis can be recognised
because of the considerable delamination of articular
Fig. 10 Dysostosis of the knee.
A 15-year-old female affected
by MPS VI. Coronal MRI fast
spin echo image (a) and spoiled
gradient echo image (b) show
an irregularly enlarged growth
plate with multiple defects and/
or erosions
Fig. 9 Multiplex dysostosis.
An 8-year-old boy with MPS
IH. Anteroposterior femoral x-
ray image (a) showing bilateral
genu valgum; proximal and
distal epiphyses are flared and
irregular. Diffuse cortical
thinning and osteopenia are also
observed (b)
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cartilage. These patients are potential surgical candidates for
total knee arthroplasty [12].
On MRI images, the growth plate is irregularly enlarged,
with multiple defects and erosions well depicted on coronal
fast spin-echo proton-density-weighted images (Fig. 10).
Almost all forms of MPS show distortion of the hand
(Fig. 11) and foot structure. Carpal and tarsal bones are
hypoplastic and irregularly shaped; the metacarpal bones
are proximally pointed, shortened and thickened. The func-
tionality of the fingers is compromised because of the bone
alterations and the thickening of the subcutaneous tissues,
resulting in a failure of a complete extension of the fingers
with a “claw hand” deformity [19, 20].
Distal ulna and radius can be hypoplastic and have a “V-
shaped” appearance; this oblique deformity of the terminal
part of both bones results in the alteration of the carpal
angle. The alterations in the skeletal anatomy, combined
with an excessive GAG deposition in the connective tissue,
cause the constriction of the median nerve resulting in carpal
tunnel syndrome [21].
Otorhinolaryngological imaging findings
Abnormal secretions and infiltration of GAG in the mouth,
nose, pharynx and larynx result in several otorhinolaryngo-
logical manifestations, sometimes the first to appear [22];
Fig. 12 Otorhinolaryngological
imaging findings. MDCT
temporal bone exam in a 12-
year-old female with MPS VI.
Axial scans presented from
caudal to cranial (a-b-c)
demonstrate nasopharyngeal




mastoid cells and left middle air
cavity (curved arrow). Other
abnormalities, including
mucosal thickening of ethmoidal
air cells, poor pneumatization of
sphenoidal bone and maxillar
sinus cavities and impacted
teeth, are also depicted. Coronal
view of temporomandibular
joints (d) shows flattened and
deformed mandibular condyles
(empty arrow)
Fig. 11 Dysostosis multiplex
of long bones. Dysostosis
multiplex of hands and wrists in
a 5-year-old boy (b) and in a
15-year-old female (d), both
affected by MPS VI
(radiographs are compared with
normal hands and wrists
belonging to subjects of the
same age, respectively a and c).
The main imaging findings
encountered in these areas are
reported: the V-shaped
hypoplastic distal ulna and
radius (white arrow), the
presence of small irregular
carpal bones (curved white
arrow), the broad and
proximally pointed short
metacarpals (white arrowhead)
and the bullet-shaped phalanges
(empty white arrow)
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ear, nose, throat and respiratory disorders are very common.
The most important otorhinolaryngological problems are
rhinitis, otitis media, and upper and lower airway obstruc-
tion [23].
Upper airway obstruction may be the consequence of
macroglossia, adenotonsillar hypertrophy and chronic
nasal discharge in combination with a decreased
temporo-mandibular joint mobility. Eustachian tube dys-
function due to enlarged adenoids and inflammation as
a consequence of abnormal storage of GAG in the
temporal bone are responsible for chronic otitis media
and conductive hearing loss [24]. A thickened, retracted
tympanic membrane and an increased attenuation of the
tympanic cavity and mastoid cells can be observed on
multidetector computed tomography (MDCT) images
(Fig. 12) [25]. Hearing impairment can also have a
sensorineural component because of GAG deposition in
the inner ear or central nervous system. The surgical
removal of the tonsils and adenoids is often required,
even though it is only a temporary solution.
Lower airway obstruction, due to tracheomalacia and
narrowing of the tracheal lumen, may lead to pneumonia
and acute respiratory insufficiency. The radiologist should
know that multiplanar reconstruction of a MDCT scan,
usually performed in these patients for the evaluation of
the atlanto-axial instability, may be an important tool to
Fig. 14 Neuroradiological
imaging findings. A 15-year-
old female affected by MPS VI.
Axial T2-weighted fast spin-
echo images (a and c) and T2-
weighted FLAIR acquisition
(b) show cribriform focal




matter lesions in the corpus





imaging findings. A 12-year-
old female affected by MPS VI.
Axial T2-weighted fast spin-
echo (a), T2-weighted FLAIR
(b) and coronal T2-weighted




white matter, with enlargement
of subarachnoid spaces in the
middle cranial fossa and
ventriculomegaly. Midsagittal
T2-weighted scan shows dilated
perivascular spaces within the
corpus callosum (Fig. 13d)
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Fig. 16 Neuroradiological imaging findings. Different severity degrees
of brain atrophy seen in threeMPS patients. Axial (a) and coronal (d) T2-
weighted fast spin-echo brain images of a 2-year-old male with MPS II
show almost normal subarachnoid and ventricular spaces. The T2-
weighted acquisitions (b and e) in a second MPS patient (a 45-year-old
female affected by Morquio disease) reveal mild enlargement of sub-
arachnoid spaces. Brain images (c and f) in a third MPS patient (an 18-
year-old female affected by MPS VI) demonstrate higher enlargement of
subarachnoid spaces, with associated dilatation of ventricles. Patients
with MPS IV and VI typically have normal intelligence and don’t show
signs of atrophy until the second decade of life; on the contrary, brain
atrophy usually develops earlier in MPS I, II, III and VII, becoming
visible during the first few years of life
Fig. 15 Neuroradiological imaging findings. Involvement of basal
ganglia in an MPS VI patient; the MR exam was acquired when the
patient was 17. Axial T2-weighted fast spin-echo (a) brain image
obtained at the level of the third ventricle with magnification focused
on basal ganglia (b) demonstrating symmetrical focal areas of
hyperintensity in the lenticular nucleus (black arrow) and in the
thalamus (black arrowhead) because of enlarged perivascular spaces.
On corresponding T2-weighted FLAIR images (c and d), these areas
(white arrow and white arrowhead) are hypointense. This typical
imaging described in the brain of patients with MPS is the “honey-
comb-like” appearance. Note also ventriculomegaly and diffuse high
signal intensity in the periventricular white matter
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assess the status of the whole airway passage. Anaesthesiologists
could use this information to improve their preoperative airway
management [26–28]. Sometimes it may be necessary to perform
a tracheostomy in order to ensure airway safety [24, 29].
Neuroradiological imaging findings
The pathogenetic substrate of central nervous system
involvement lies in the abnormal accumulation of
















Fig. 17 Neuroradiological imaging findings. Brain atrophy in a patient
affected by MPS VI; the patient started treatment with enzyme replace-
ment therapy (ERT) in 2005. The studies were collected from 2005 (when
she was 11 years old) to 2012 (at the age of 17). The patient shows a
moderate degree of brain atrophy, with mild enlargement of the Sylvian
fissure on axial images (a, c, e, g); on sagittal acquisitions there are some
focal lesions along the corpus callosum and an enlargement of cisterna
magna (b, d, f, h). The brain atrophy does not show significant progres-
sion through the different MR examinations. Despite encouraging results
observed in patients with MPS II, the ERT therapy does not seem to
improve the appearance of neuroradiological imaging findings; the en-
zymes do not cross the haematoencephalic barrier. However, new evi-
dence is needed in order to investigate the progression of
neuroradiological imaging findings after treatment
Insights Imaging (2013) 4:443–459 453
mucopolysaccharides within perivascular spaces and neuro-
axonal units with an adversely affected myelin turnover [30].
On the basis of MRI findings a large spectrum of severity
can be recognised, from negligible to severe. Here we de-
scribe the main neuroradiological features: abnormal signal
intensity in the white matter and in the basal ganglia, dila-
tation of periventricular spaces, widening of cortical sulci,
brain atrophy and enlargement of extraventricular spaces,
and spinal cord compression. Recently, a few cases of
closed cephalocele have been reported in the literature [31].
Abnormal signal intensity in the white matter
and in the basal ganglia
One of the typical neuroradiological imaging findings is
represented by focal or diffuse white matter lesions,
detected as areas of high signal intensity on T2-
weighted sequences. These alterations show an increase
with aging, becoming more extensive with time.
Diffuse white matter lesions usually show a symmetrical
periventricular distribution, although they can also be found as
patchy lesions in the subcortical region (Fig. 13). They derive
from the delay of myelination in young children and progres-
sive demyelination in the course of the disease; these lesions
can also reflect gliosis [32, 33]. Focal white matter lesions
consist of multiple small spot-like areas isointense to the
cerebrospinal fluid (CSF) on fluid attenuated inversion recov-
ery (FLAIR), T2-weighted and T1-weighted sequences
(Fig. 14) because of periventricular space enlargement.
The corpus callosum, best depicted on sagittal images, is
sometimes the only location of these lesions, although they
can also be encountered in the parietal and occipital lobe, in
the basal ganglia, in the thalamus and at the grey-white
matter junction level [32–34]. A typical imaging feature in
the brain of patients with MPS is the “honeycomb-like”
appearance in the basal ganglia and thalami (Fig. 15); this
imaging finding has been observed in patients with MPS I,
II and IIIB [35, 36]. Two theories have been proposed to
explain the pathogenesis of basal ganglia involvement; the
first concerns the accumulation of GAGs in neurons and
astrocytes, leading to neuronal loss and demyelination; an-
other theory maintains that the basal ganglia appearance
could be related to an increase of fluid content in the
periventricular spaces.
The pathogenesis of enlargement of perivascular spaces is
not entirely clear [34]. Two main hypotheses have been for-
mulated: accumulation of GAG around vessels [37] and im-
pairment of cerebrospinal fluid reabsorption (caused by the
deposit of mucopolysaccharides in the leptomeninges) [32].
In addition, in the white matter of parietal and occipital
lobes, multifocal variable-sized areas of high signal
intensity—which doesn’t match that of cerebrospinal
fluid—may be detected on FLAIR and T2-weighted
sequences; these lesions, probably due to gliosis, tend to
become extensive and confluent.
Hydrocephalus and brain atrophy
Ventricular enlargement, with or without involvement of the
subarachnoid spaces, is a common finding in patients with
MPS (Figs. 13, 14, 15, 16 and 17). Communicating hydro-
cephalus may be the consequence of either diffuse brain
atrophy or reabsorption failure of cerebrospinal fluid due
to dysfunction of the arachnoid granulations. A cystic-
appearing enlargement of the cerebellomedullary and/or
suprasellar cisterna has been described [34].
The atrophy of the brain, probably due to neuronal death
and myelin loss, is a common feature in MPS and is seen as
widened subarachnoid spaces and enlargement of the
Fig. 19 Involvement of the craniocervical junction: recurrence after
surgery. Craniocervical junction appearance in an MPS VI patient
before (a) and after (a”) the decompressive surgical procedure: note
the improvement in size of the craniocervical junction, with enlarge-
ment of subarachnoid spaces after the surgical procedure. b and b”
show recurrence of stenosis of the craniocervical junction in an MPS
IV patient 3 and 12 years respectively after surgery; the recurrence is
due to progression of GAG accumulation
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cortical sulci. The neuronal death could be explained by
ischaemic damages due to the progressive accumulation of
GAG in blood vessels [38]; on the other hand, the neuronal
death could be caused by direct intracellular storage of
GAG.
The MRI evaluation of these findings is a useful marker
of axonal loss [16]. Brain atrophy usually develops earlier in
MPS I, II, III and VII, becoming visible during the first few
years of life; on the contrary, patients with MPS IV and VI
typically have normal intelligence and don’t show signs of
atrophy until the second decade of life.
The different degree of brain atrophy has been recently
evaluated for monitoring disease progression and response
to therapy [15, 33]; these authors reported a classification
using the method introduced by Lee et al. [38]. Brain atro-
phy could be:
& absent
& mild (widening of the sylvian and interhemispheric fis-
sures <3 mm, but not all sulci are involved)
& moderate (widening of all fissures and sulci between 3–
5 mm with visualisation of the entire mesencephalic
cistern)
Fig. 21 Optic nerve
involvement. Optic nerve
involvement in the same MPS
patient as Fig. 14: axial (a),
coronal (b) and sagittal (c) T2-
weighted fast spin-echo
acquisitions show widening of
the optic nerve sheath, with
enlargement of the perineural
CSF space; angulation of the
right optic nerve is also
observed
Fig. 20 MRS. (Legend: mIns =
myo-inositol; Cho = choline;
Cr = creatine; NAA = N-acetyl-
aspartate). Multivoxel MRS
performed on an MPS VI
patient; after post-processing
analysis, two spectroscopic
graphics are shown in a and c
(corresponding voxels in b and
d). The mIns/Cr ratio was found
to have slightly increased in the
white matter lesion and in the
gray matter area (respectively
values of 0.68 and 0.59). As
reported by Vedolin et al. [39],
cerebral GAG deposition
induces changes in glial cells,
with a consequent increase in
the mIns/Cr ratio
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& severe (widening of all fissures and sulci >5 mm with
definite loss of cortex and white matter).
A strong correlation was found between severity of brain
atrophy and cognitive impairment in MPS [33, 39], whereas
other authors did not find the same correlation [40].
Spinal cord compression
Compression of the spinal cord most frequently occurs at
the atlanto-axial (C1-C2) joint (Figs. 18 and 19), especially
affecting patients with MPS IV and VI. Many of these
patients suffer from several craniocervical junction abnor-
malities due to structural defects involving the spine. The
most important one is atlanto-axial subluxation, which is the
result of several causes: laxity of the transverse ligament,
dural thickening resulting from deposition of collagen and
GAGs, hypoplasia or absence of the odontoid, anterior soft
tissue mass of the odontoid (representing a combination of
unossified fibrocartilage and reactive changes) and indenta-
tion of the posterior arch of C1 [33]. The anomaly of the
odontoid process ranges in severity from total aplasia to a
triangular-shaped configuration with a loss in vertical height
and a broad-based tip [41]. Chronic subluxation of the C1-
C2 level may lead to a ligamentous hypertrophy and to
further narrowing in the region of the craniocervical junc-
tion with the consequence of additional cord compression.
Another cause of cord compression in these patients is
gibbous formation in the thoracic spine, resulting from the
malformations of vertebral bodies (most common in
Morquio disease). Compressive cervical myelopathy is a
critical problem since the involvement of the bulbar-spine
junction may lead to central respiratory failure [33].
Magnetic resonance spectroscopy (MRS)
MRS (Fig. 20) is a non-invasive imaging technique able to
provide information about tissue molecular structures. Brain
Fig. 23 Closed encephalocele in MPS VI. Closed encephalocele in
patient affected by MPS VI (same patient as in Fig. 12). Coronal
MDCT image of middle cranial fossa (a), obtained at the level of the
pterygoid processes, revealing a bone depression of the right great
wing of the sphenoid. The corresponding coronal T2-weighted MRI
image (b) demonstrates the pouch filled with cerebrospinal fluid and
brain parenchyma
Fig. 22 Closed encephalocele
in MPS VI. MRI of the brain of
an 18-year-old girl affected by
MPS VI. Axial T2-weighted
(a), coronal T2-weighted (b),
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application leads to revealing the concentration of brain
metabolites and can be used to monitor biochemical changes
in brain diseases.
Numerous studies have suggested a contribution of MRS
to mucopolysaccharidoses assessment [42, 43].
Davison et al. [42, 43] found a reduction of the white
matter N-acetylaspartate/creatine (NAA/Cr) ratio in MPS
IVa and II proportional to cognitive indices and to disease
progression [42, 43], while Vedolin did not find a significant
difference in the NAA/Cr ratio between patients with and
without cognitive impairment; Vedolin found instead an
elevated myo-inositol/creatine (mIns/Cr) ratio in patients
with cognitive impairment [39]. The increase in the mIns/Cr
ratio is interpreted as a possible marker of glial activity
(Fig. 20).
Takahashi et al. [44] measured presumptive mucopoly-
saccharides in white matter lesions and in white matter
without lesions and compared the presumptive MPS/Cr
ratios before and after bone marrow transplantation (BMT)
[44]. They found a reduction in mucopolysaccharides in
white matter without lesions after the BMT; they also found
a correlation between mucopolysaccharide accumulation
and neuronal damage resulting in a decreased NAA/Cr ratio
[44].
In summary, new evidence is needed in order to under-
stand the real value of MRS in the evaluation of neurolog-
ical involvement.
Miscellaneous
Another commonly found sign in MPS patients is
macrocephaly, resulting from hydrocephalus combined with
abnormal accumulation of incompletely broken down
GAGs within the brain, meninges and skull. Macrocephaly
is diagnosed when the circumference of the head exceeds
normal values by more than two standard deviations. Other
dysmorphic features, such as frontal prominence,
scaphocephaly, a short neck and enlarged tongue, can be
observed.
Several orbital abnormalities can be found: thickening of
the sclera and of the optic nerve sheath, optic canal
narrowing and optic nerve atrophy (Fig. 21).
Finally, another imaging features reported in literature
[31] is the closed encephalocele (Figs. 22 and 23); regarding
this point, the presence of parenchymal/meningeal hernia-
tion at the level of the anterior or middle cranial fossa has
been described as a characteristic neuroradiological feature
of patients affected by MPS II. Instead of the term
“meningoencephalocele,” which indicates the herniation of
brain and/or meningeal tissue through a bone defect, the
term “closed cephalocele” has been proposed to describe
this skull abnormality because the protrusion of intracranial
structures occurs without a detectable bone defect. The
etiopathogenesis of this further manifestation seems to be
related to an increased intracranial pressure and/or an altered
bone maturation process. CT and MRI reveal a variable-
sized pouch filled with brain parenchyma and cerebrospinal
fluid, delimited by a bone wall and usually located in the
anterior cranial fossa at the level of the lamina cribrosa as a
weak area of the skull. The radiologist should look out for
the presence of a closed cephalocele because it may interfere
with rhinosurgery and cause epilepsy [31].
Conclusion
Knowledge of radiological and neuroradiological appearances
of MPS is essential for radiologists. Skeletal X-ray and MRI
may show specific features in MPS patients, although it is not
possible to accurately differentiate between MPS types based
on skeletal and neurological characteristics. The evaluation of
these imaging findings is useful for suggesting and supporting
MPS as a possible diagnosis, usually obtained by laboratory
analysis, for monitoring the chronic and progressive course of
the disease, for surgical and medical planning and for
assessing the impact of therapy.
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